Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3205227 | Journal of the American Academy of Dermatology | 2013 | 14 Pages |
Abstract
Topical treatments including emollients, calcipotriol ointment, and liarozole cream seem to have therapeutic benefit and a good safety profile, although the use of topical calcipotriol is limited by a maximum weekly dose of 100 g. The advantage of oral liarozole over acitretin is uncertain. Multicenter trials comparing oral and topical interventions and evaluation of long-term outcomes are needed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Angela MD, Beatriz MD, Ana MD, Ignacio PhD,